T-DM1 targets HER2 on the cell surface; after internalization, the DM1 payload binds beta-tubulin to disrupt microtubules and induce mitotic arrest/apoptosis. Cells expressing beta-tubulin alone are not targeted—killing requires HER2-mediated delivery.